Omeros Corporation (OMER) - Buy, Sell or Hold?
Sector: Consumer Durables Sub-Sector: Major Pharmaceuticals
| Trade Date | Current Candlestick Pattern | Previous Candlestick Pattern | When | Performance Since |
|---|---|---|---|---|
| Tue, 28 Nov 2017 | None | Bullish Engulfing | Wed, 22 Nov 2017 | 0.8% |
| ***Stock database and scans are updated around midnight (New York time) every trading day. | ||||
18.91 0.00 (0%) Nov 28 4:00pm EST
Open: 18.35 Range: 18.00 - 18.97 Vol: 730.43K Avg Vol: 784.36K
Analyze "OMER" - FREE 30 Day Trial of Market Analyst 7
Short Term: Trend is Up
Last Trade is above the 5 day moving average at 18.66
Medium Term: Trend is Up
Last Trade is above the 20 day moving average at 17.11
Last Trade is above the 50 day moving average at 18.72
Long Term: Trend is Up
Last Trade is above the 200 day moving average at 17.88
* Data normalized for Splits & Dividends. Report data issues
How to use this info: Stock Timing With Moving Averages
How to use this info: Stock Timing With Moving Averages
News on "OMER" Stock
- Omeros Finalizes Clinical Plan For Kidney Disease Treatment, Reports Additional Positive Phase 2 Data
- Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy
- Omeros Corporation Announces Record High Quarterly Revenue Results for the Fourth Quarter 2018
- Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Parts, Bruker, Omeros, and Aimmune Therapeutics — Discovering Underlying Factors of Influence
- Omeros Establishes Independent Academic Leadership Committee for its OMS721 Phase 3 Clinical Program in IgA Nephropathy
| Consumer Durables Stocks Above 200 Day Moving-Average | |||
|---|---|---|---|
| Ticker | Name | Trend Analysis | Support/Resistance |
| CYCCP | Cyclacel Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| ECYT | Endocyte, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| LGND | Ligand Pharmaceuticals Incorporated | Buy, Sell or Hold | Trading Levels & Pivots |
| ARNA | Arena Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| EDUC | Educational Development Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| GLGL | GLG Life Tech Corp | Buy, Sell or Hold | Trading Levels & Pivots |
| HOFT | Hooker Furniture Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| MNKD | MannKind Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| ALNY | Alnylam Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| SCSS | Select Comfort Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
Stock Trend Analysis - Buy, Sell or Hold "Omeros Corporation" (OMER)?
OMER is in a long term trading range with an upward bias. The last 52 weeks has seen this stock maintain an upward swing with about 76% of the time spent trading above the 200 day moving average. For the medium term, the 50 day moving average is generally in a trading range with a bearish downward bias. The 20 day moving average is also in a trading range with a similar bearish downside bias. These may be early indications of a trend reversal but it is still too early to confirm. The long term trend remains up and the higher probability trade is to selectively buy the dips. A successful test of the 200 SMA currently near 17.88 would be a good place to start scaling in a long position. Click here for the latest support & resistance levels to help you finetune your entry into or exit out of "OMER".The analyst consensus estimates for the 1 year price target for this stock is $29.50* (*source: Yahoo Finance).